Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85


Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Fuge J, Gall H, Gerhardt F, Ghofrani HA, Gunkel H, Grünig E, Halank M, Heine A, Klose H, Lange TJ, Neurohr C, Nickolaus K, Opitz CF, Rosenkranz S, Seyfarth HJ, Tello K, Ewert R, Olsson KM.

Pulm Circ. 2020 Mar 13;10(1):2045894020910136. doi: 10.1177/2045894020910136. eCollection 2020 Jan-Mar.


Patients' and Healthcare Professionals' Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey.

Lancaster LH, Valenzuela C, Mason W, Neurohr C, Ripamonti E, Kirchgaessler KU, Cottin V.

Pulm Ther. 2020 Mar 19. doi: 10.1007/s41030-020-00111-y. [Epub ahead of print]


Variables predicting weaning outcome in prolonged mechanically ventilated tracheotomized patients: a retrospective study.

Ghiani A, Paderewska J, Sainis A, Crispin A, Walcher S, Neurohr C.

J Intensive Care. 2020 Feb 21;8:19. doi: 10.1186/s40560-020-00437-4. eCollection 2020.


Safety and Efficacy of Steroid Pulse Therapy for Acute Loss of FEV1 in Lung Transplant Recipients After Exclusion of Acute Cellular Rejection.

Munker D, Arnold P, Veit T, Leuschner G, Ceelen F, Barnikel M, Schmitzer M, Barton J, Sonneck T, Milger K, Matthes S, Schiopu S, Kauke T, Weig T, Kneidinger N, Behr J, Neurohr C.

Transplant Proc. 2020 Jan - Feb;52(1):309-314. doi: 10.1016/j.transproceed.2019.10.013. Epub 2020 Jan 8.


A Compact Device for the Integrated Filtration, Drying, and Mechanical Processing of Active Pharmaceutical Ingredients.

Capellades G, Neurohr C, Azad M, Brancazio D, Rapp K, Hammersmith G, Myerson AS.

J Pharm Sci. 2020 Mar;109(3):1365-1372. doi: 10.1016/j.xphs.2019.12.011. Epub 2019 Dec 20.


[Rheumathism and pneumology].

Jakubczyc A, Neurohr C.

Orthopade. 2019 Nov;48(11):942-948. doi: 10.1007/s00132-019-03806-6. Review. German.


Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease.

Schiopu SRI, Zacherl M, Todica A, Bartenstein P, Milger K, Leuschner G, Munker D, Bauer M, Massberg S, Behr J, Neurohr C, Huber BC, Kneidinger N.

J Nucl Cardiol. 2019 Aug 19. doi: 10.1007/s12350-019-01851-4. [Epub ahead of print]


Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation.

Veit T, Leuschner G, Sisic A, Ceelen F, Munker D, Schmitzer M, Weig T, Michel S, Schneider C, Meiser B, Crispin A, Neurohr C, Behr J, Milger K, Kneidinger N.

Am J Transplant. 2019 Aug;19(8):2358-2365. doi: 10.1111/ajt.15378. Epub 2019 Apr 29.


The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J.

Respir Res. 2019 Mar 15;20(1):59. doi: 10.1186/s12931-019-1020-3.


Real-life data on Selexipag for the treatment of pulmonary hypertension.

Barnikel M, Kneidinger N, Klenner F, Waelde A, Arnold P, Sonneck T, Behr J, Neurohr C, Milger K.

Pulm Circ. 2019 Jan-Mar;9(1):2045894019832199. doi: 10.1177/2045894019832199.


A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation.

Gottlieb J, Neurohr C, Müller-Quernheim J, Wirtz H, Sill B, Wilkens H, Bessa V, Knosalla C, Porstner M, Capusan C, Strüber M.

Am J Transplant. 2019 Jun;19(6):1759-1769. doi: 10.1111/ajt.15251. Epub 2019 Feb 5.


[Diagnosis and Treatment of Interstitial Lung Diseases].

Jakubczyc A, Neurohr C.

Dtsch Med Wochenschr. 2018 Dec;143(24):1774-1777. doi: 10.1055/a-0622-9299. Epub 2018 Dec 3. German.


Asthma features in severe COPD: Identifying treatable traits.

Matthes S, Stadler J, Barton J, Leuschner G, Munker D, Arnold P, Villena-Hermoza H, Frankenberger M, Probst P, Koch A, Kneidinger N, Milger K, Behr J, Neurohr C.

Respir Med. 2018 Dec;145:89-94. doi: 10.1016/j.rmed.2018.10.027. Epub 2018 Oct 26.


Endobronchial One-Way Valve Therapy Facilitates Weaning from Extracorporeal Membrane Oxygenation in a Patient with ARDS and Persistent Air Leak.

Ghiani A, Hansen M, Tsitouras K, Neurohr C.

Case Rep Crit Care. 2018 Sep 25;2018:9736217. doi: 10.1155/2018/9736217. eCollection 2018.


Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.


Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.

Winkler A, Kahnert K, Behr J, Neurohr C, Kneidinger N, Hatz R, Dressel H, Radtke T, Jörres RA.

Respir Res. 2018 Sep 10;19(1):171. doi: 10.1186/s12931-018-0881-1.


General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Grünig E, Benjamin N, Krüger U, Kaemmerer H, Harutyunova S, Olsson KM, Ulrich S, Gerhardt F, Neurohr C, Sablotzki A, Halank M, Marra AM, Kabitz HJ, Thimm G, Fliegel KG, Klose H.

Int J Cardiol. 2018 Dec 1;272S:30-36. doi: 10.1016/j.ijcard.2018.08.085. Epub 2018 Aug 27. Review.


[What rheumatologists can learn from pneumologists].

Leuschner G, Neurohr C.

Z Rheumatol. 2018 Aug;77(6):477-483. doi: 10.1007/s00393-018-0507-5. Review. German.


Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management.

Leuschner G, Reiter F, Stocker F, Crispin A, Kneidinger N, Veit T, Klenner F, Ceelen F, Zimmermann G, Leuchte H, Reu S, Dinkel J, Behr J, Neurohr C.

Lung. 2018 Aug;196(4):401-408. doi: 10.1007/s00408-018-0123-9. Epub 2018 May 14.


Five-year experience using the Lung Allocation Score: the Munich Lung Transplant Group.

Schuba B, Scheklinski M, von Dossow V, Schneider C, Preissler G, Kneidinger N, Neurohr C, Michel S, Hagl C, Schramm R.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):328-333. doi: 10.1093/ejcts/ezy035.


Posaconazole liquid vs tablet formulation in lung transplant recipients.

Stelzer D, Weber A, Ihle F, Matthes S, Ceelen F, Zimmermann G, Kneidinger N, Schramm R, Winter H, Zoller M, Vogeser M, Behr J, Neurohr C.

Mycoses. 2018 Mar;61(3):186-194. doi: 10.1111/myc.12724. Epub 2017 Nov 22.


Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy.

Leuschner G, Stocker F, Veit T, Kneidinger N, Winter H, Schramm R, Weig T, Matthes S, Ceelen F, Arnold P, Munker D, Klenner F, Hatz R, Frankenberger M, Behr J, Neurohr C.

J Heart Lung Transplant. 2017 Jul 5. pii: S1053-2498(17)31886-7. doi: 10.1016/j.healun.2017.07.002. [Epub ahead of print]


Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Frankenberger M, Behr J.

Respir Res. 2017 Jul 14;18(1):139. doi: 10.1186/s12931-017-0621-y.


Lung volumes predict survival in patients with chronic lung allograft dysfunction.

Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Dinkel J, Königshoff M, Weig T, Schramm R, Winter H, Behr J, Neurohr C.

Eur Respir J. 2017 Apr 12;49(4). pii: 1601315. doi: 10.1183/13993003.01315-2016. Print 2017 Apr.


[Current Developments in Lung Transplantation].

Neurohr C, Ceelen F.

Dtsch Med Wochenschr. 2017 Apr;142(7):517-520. doi: 10.1055/s-0042-122720. Epub 2017 Apr 7. German. No abstract available.


Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.

Stelzer D, Weber A, Ihle F, Matthes S, Ceelen F, Zimmermann G, Kneidinger N, Schramm R, Winter H, Zoller M, Vogeser M, Behr J, Neurohr C.

Ther Drug Monit. 2017 Apr;39(2):93-101. doi: 10.1097/FTD.0000000000000371.


Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Kim NH, D'Armini AM, Grimminger F, Grünig E, Hoeper MM, Jansa P, Mayer E, Neurohr C, Simonneau G, Torbicki A, Wang C, Fritsch A, Davie N, Ghofrani HA.

Heart. 2017 Apr;103(8):599-606. doi: 10.1136/heartjnl-2016-309621. Epub 2016 Dec 23.


An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe.

Ruttens D, Verleden SE, Bijnens EM, Winckelmans E, Gottlieb J, Warnecke G, Meloni F, Morosini M, Van Der Bij W, Verschuuren EA, Sommerwerck U, Weinreich G, Kamler M, Roman A, Gomez-Olles S, Berastegui C, Benden C, Holm AM, Iversen M, Schultz HH, Luijk B, Oudijk EJ, Kwakkel-van Erp JM, Jaksch P, Klepetko W, Kneidinger N, Neurohr C, Corris P, Fisher AJ, Lordan J, Meachery G, Piloni D, Vandermeulen E, Bellon H, Hoffmann B, Vienneau D, Hoek G, de Hoogh K, Nemery B, Verleden GM, Vos R, Nawrot TS, Vanaudenaerde BM.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600484. doi: 10.1183/13993003.00484-2016. Print 2017 Jan.


Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial.

Grünig E, Benjamin N, Lange TJ, Krueger U, Klose H, Neurohr C, Wilkens H, Halank M, Seyfarth HJ, Held M, Traube A, Pernow M, Grover ER, Egenlauf B, Gerhardt F, Viethen T, Rosenkranz S.

Respiration. 2016;92(6):362-370. Epub 2016 Oct 27.


[General and supportive therapy of pulmonary arterial hypertension].

Grünig E, Benjamin N, Krüger U, Kaemmerer H, Harutyunova S, Olsson KM, Ulrich S, Gerhardt F, Neurohr C, Sablotzki A, Halank M, Kabitz HJ, Thimm G, Fliegel KG, Klose H.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S26-S32. Epub 2016 Oct 19. Review. German.


Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.

Fernandez IE, Greiffo FR, Frankenberger M, Bandres J, Heinzelmann K, Neurohr C, Hatz R, Hartl D, Behr J, Eickelberg O.

Eur Respir J. 2016 Oct;48(4):1171-1183. doi: 10.1183/13993003.01826-2015. Epub 2016 Sep 1.


Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study.

Konstantinides SV, Barco S, Rosenkranz S, Lankeit M, Held M, Gerhardt F, Bruch L, Ewert R, Faehling M, Freise J, Ghofrani HA, Grünig E, Halank M, Heydenreich N, Hoeper MM, Leuchte HH, Mayer E, Meyer FJ, Neurohr C, Opitz C, Pinto A, Seyfarth HJ, Wachter R, Zäpf B, Wilkens H, Binder H, Wild PS.

J Thromb Thrombolysis. 2016 Nov;42(4):600-9. doi: 10.1007/s11239-016-1415-7.


Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis.

Bonella F, Kreuter M, Hagmeyer L, Neurohr C, Keller C, Kohlhaeufl MJ, Müller-Quernheim J, Milger K, Prasse A; German Nintedanib Compassionate Use Consortium.

Respiration. 2016;92(2):98-106. doi: 10.1159/000448288. Epub 2016 Aug 20.


Suspected pulmonary embolism in patients with pulmonary fibrosis: Discordance between ventilation/perfusion SPECT and CT pulmonary angiography.

Leuschner G, Wenter V, Milger K, Zimmermann GS, Matthes S, Meinel FG, Lehner S, Neurohr C, Behr J, Kneidinger N.

Respirology. 2016 Aug;21(6):1081-7. doi: 10.1111/resp.12797. Epub 2016 Apr 7.


A novel role of MMP-13 for murine DC function: its inhibition dampens T-cell activation.

Bartmann J, Frankenberger M, Neurohr C, Eickelberg O, Noessner E, von Wulffen W.

Int Immunol. 2016 Oct;28(10):473-487. Epub 2016 Feb 26.


Core Muscle Size Predicts Postoperative Outcome in Lung Transplant Candidates.

Weig T, Milger K, Langhans B, Janitza S, Sisic A, Kenn K, Irlbeck T, Pomschar A, Johnson T, Irlbeck M, Behr J, Czerner S, Schramm R, Winter H, Neurohr C, Frey L, Kneidinger N.

Ann Thorac Surg. 2016 Apr;101(4):1318-25. doi: 10.1016/j.athoracsur.2015.10.041. Epub 2016 Jan 12.


Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.

Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JS.

PLoS One. 2015 Dec 2;10(12):e0141911. doi: 10.1371/journal.pone.0141911. eCollection 2015.


Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary Fibrosis.

Leuchte HH, Mernitz P, Baezner C, Baumgartner RA, von Wulffen W, Neurohr C, Behr J.

Respiration. 2015;90(6):460-7. doi: 10.1159/000441302. Epub 2015 Nov 27.


Combined Lung and Liver Transplantation With Extracorporeal Membrane Oxygenation Instead of Cardiopulmonary Bypass.

Scheiermann P, Czerner S, Kaspar M, Schramm R, Winter H, Wimmer CD, Guba M, Stangl M, Faltenbacher V, Ripperger M, Frey L, Neurohr C, Behr J, Meiser B, Hagl C, Zwissler B, von Dossow V.

J Cardiothorac Vasc Anesth. 2016 Apr;30(2):437-42. doi: 10.1053/j.jvca.2015.06.034. Epub 2015 Jun 30. No abstract available.


Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.

Milger K, Kneidinger N, Neurohr C, Reichenberger F, Behr J.

Eur Respir J. 2015 Oct;46(4):1217-21. doi: 10.1183/13993003.00584-2015. Epub 2015 Sep 4. No abstract available.


The Munich Lung Transplant Group: Intraoperative Extracorporeal Circulation in Lung Transplantation.

Hoechter DJ, von Dossow V, Winter H, Müller HH, Meiser B, Neurohr C, Behr J, Guenther S, Hagl C, Schramm R.

Thorac Cardiovasc Surg. 2015 Dec;63(8):706-14. doi: 10.1055/s-0035-1556873. Epub 2015 Aug 20.


[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis].

Behr J, Bonella F, Bonnet R, Gläser S, Grohé C, Günther A, Koschel D, Kreuter M, Kirsten D, Krögel C, Markart P, Müller-Quernheim J, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Wirtz H, Witt C, Costabel U.

Pneumologie. 2015 Aug;69(8):455-8. doi: 10.1055/s-0034-1392602. Epub 2015 Jul 30. German.


Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.

Kauke T, Kneidinger N, Martin B, Dick A, Schneider C, Schramm R, Meimarakis G, Preissler G, Eickelberg O, von Dossow V, Behr J, Hatz R, Neurohr C, Winter H.

Tissue Antigens. 2015 Sep;86(3):178-85. doi: 10.1111/tan.12626. Epub 2015 Jul 23.


FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.

Staab-Weijnitz CA, Fernandez IE, Knüppel L, Maul J, Heinzelmann K, Juan-Guardela BM, Hennen E, Preissler G, Winter H, Neurohr C, Hatz R, Lindner M, Behr J, Kaminski N, Eickelberg O.

Am J Respir Crit Care Med. 2015 Aug 15;192(4):455-67. doi: 10.1164/rccm.201412-2233OC.


Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.

Leuchte HH, Baezner C, Baumgartner RA, Muehling O, Neurohr C, Behr J.

Heart. 2015 Jun;101(12):972-6. doi: 10.1136/heartjnl-2015-307529.


Changes in the current classification of IIP: A critical review.

Neurohr C, Behr J.

Respirology. 2015 Jul;20(5):699-704. doi: 10.1111/resp.12553. Epub 2015 May 26. Review.


Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Jul;46(1):186-96. doi: 10.1183/09031936.00217614. Epub 2015 Apr 2.


An unusual case of primary hepatic lymphoma mimicking sarcoidosis in MRI.

Do TD, Neurohr C, Michl M, Reiser MF, Zech CJ.

Acta Radiol Short Rep. 2014 May 10;3(4):2047981613493625. doi: 10.1177/2047981613493625. eCollection 2014 May.


Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.

Kneidinger N, Giessen C, von Wulffen W, Milger K, Schramm R, Jäger G, Nitschko H, Striebinger H, Behr J, Neurohr C.

Int J Infect Dis. 2014 Nov;28:140-2. doi: 10.1016/j.ijid.2014.06.009. Epub 2014 Sep 26.

Supplemental Content

Loading ...
Support Center